Hearing Loss and Diabetes: You Might Not Know What You're Missing
Authors: Keiko Hirose
Journal: Annals of Internal Medicine (2008)

Editorials1 July 2008Hearing Loss and Diabetes: You Might Not Know What You're MissingFREEKeiko Hirose, MDKeiko Hirose, MDFrom Washington University, St. Louis, MO 63110.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-149-1-200807010-00232 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Diabetes is a complex multisystem disease that requires routine monitoring for known complications affecting the renal, visual, and peripheral nervous systems. Research has hinted at an increased risk for hearing loss in diabetic patients, but confounders of noise exposure, ototoxic drug exposure, presbycusis, and known syndromes that affect both glucose metabolism and cochlear function make it difficult to establish this association (1–5). Currently, there are no formal recommendations for screening for hearing loss in diabetic patients (6).The article by Bainbridge and colleagues (7) in this issue reports on the risk for hearing loss in persons with self-reported diabetes. In a cross-sectional study, they used the National Health and Nutrition Examination Survey to determine the relative risk for sensorineural hearing loss in a community-based random sample of patients who reported a history of diabetes. They found that persons with diabetes were at increased risk for hearing loss (adjusted odds ratio, 2.2 to 2.4). The degree of hearing loss ranged from mild to moderate, causing deficits that would be difficult to detect without screening but would pose substantial impairment for communicating.One previous study (2) provided evidence that diabetes affects hearing. Cullen and Cinnamond (2), who used a large population-based data set, reported an odds ratio for hearing loss of 1.41 in non–insulin-dependent diabetic patients. A possible explanation for the divergent results between this study and Bainbridge and colleagues' (7) is that Cullen and Cinnamond (2) excluded patients younger than age 48 years and patients with non–insulin-dependent diabetes. The exclusion of young persons is important because Bainbridge and colleagues found the strongest association between diabetes and hearing loss in the youngest age group, in which other causes of hearing loss (which would dilute the effect of diabetes on the incidence of hearing loss) are uncommon.The pathophysiology underlying diabetes-associated hearing loss is unclear, which allows for speculation. A leading candidate explanation is the effect of diabetes-related microvascular disease on the cochlea (8). Unlike the retina, the cochlea is virtually impossible to examine visually, and its microcirculation is embedded in the temporal bone, which cannot be effectively examined, even under surgical conditions. Previous postmortem studies have invoked microvascular disease affecting the stria vascularis, the organ responsible for generating endolymph, which serves as the driving force for mechanotransduction of hair cells. Temporal bone studies have demonstrated pathology in the stria vascularis and in hair cells of postmortem studies of the inner ear in diabetic adults (9, 10). Despite these findings, the pathophysiology of impaired hearing in diabetes remains uncertain. First, pathologic change in the stria vascularis and the outer hair cells is a known concomitant of aging. Second, some investigators have looked for these changes in diabetic patients and failed to find them. Third, studies in diabetic animals have shown decreased hearing function but no abnormality in hair cells or the stria vascularis (11, 12).Although hearing loss researchers have a large battery of physiologic tests to help localize a lesion—including studies of outer hair cell function, eighth nerve function, behavioral response to sound, localization of sound, detection of words in noise, and central auditory processing—we do not have the cochlear equivalent of a fundoscopic examination. Thus, we have a very limited ability to confirm the enticing hypothesis of impaired microcirculation of the ear (8). Two previous studies (13, 14) indicate that distortion product otoacoustic emissions can detect early hearing loss in diabetic patients. Distortion products are an objective physiologic test of outer hair cells; they are measured through microphone recordings of the sounds reflected back from the ear in response to 2 pure tone stimuli. This form of hearing test is commonly used to evaluate neonates for universal newborn hearing screening. The 2 studies indicate that distortion product otoacoustic emissions are more sensitive than routine behavioral audiometry in detecting cochlear dysfunction in diabetic patients (13, 14). Downstream effects of hyperglycemia, such as elevated glucose levels in the cerebrospinal fluid or in the perilymph, could also contribute to cochlear dysfunction in diabetic patients. Metabolic studies in animals have demonstrated that glucose can pass from serum to the perilymph and endolymph, but no one has convincingly shown elevated glucose levels in these fluids in animals with hyperglycemia (15).This study reveals some potential directions for future research. Can we develop medical or surgical therapies that could halt the progression of diabetic cochleopathy? The possible relationship of glucose levels in the serum, perilymph, and endolymph suggests other potential avenues of investigation that could prove helpful in managing diabetes-associated hearing loss. Evidence has shown that close monitoring and regulation of blood glucose decreases the likelihood of renal and retinal complications of diabetes. Would tighter glycemic control have a similar protective effect against the development of hearing loss? The existence of diabetes-related hearing loss increases the possibility of a corresponding condition: diabetic vestibulopathy (16). Physicians have attributed impaired balance and gait in diabetic patients to impaired proprioception. It is possible that diabetic patients also have impaired vestibular input because the microcirculation that maintains cochlear function is entangled with the circulation of the vestibular organs.What are the clinical implications of diabetes-related hearing loss? On the basis of Bainbridge and colleagues' study, the American Diabetes Association could recommend that physicians include routine audiometry in the annual test battery for diabetic patients. Bainbridge and colleagues provide level B evidence from a large cohort in a well-conducted cross-sectional study to support this recommendation. However, their study cannot tell us whether the severity of diabetes is related to the likelihood of hearing loss. Its cross-sectional design means that we cannot be sure that hearing loss in diabetic persons was permanent. Although unlikely, some of the patients with hearing loss may have had a temporary shift in their hearing threshold. Nevertheless, pure tone audiometry is a relatively low-cost test that can lead to interventions—specifically, hearing amplification—that can improve an individual's productivity and quality of life. However, at this time, we do not have therapies to restore hearing in patients with progressive hearing loss, and this study does not provide evidence that hearing loss can be either prevented or stopped as a result of early detection.Counseling patients with mild to moderate hearing loss to avoid loud, prolonged noise exposure and ototoxic medications can be helpful in eliminating other sources of progressive hearing loss. We have few current therapeutic options for progressive hearing loss from any cause, and the study of hearing loss in diabetic patients could lead to important progress in new techniques of studying and treating microvascular disease of the inner ear. In many cases of mild to moderate hearing loss, patients are not aware of what they cannot hear; thus, screening for hearing loss in individuals at risk could lead to interventions that would affect their ability to communicate, their productivity, and their safety.Keiko Hirose, MDWashington UniversitySt. Louis, MO 63110References1. Dalton DS, Cruickshanks KJ, Klein R, Klein BE, Wiley TL. Association of NIDDM and hearing loss. Diabetes Care. 1998;21:1540-4. [PMID: 9727906] CrossrefMedlineGoogle Scholar2. Cullen JR, Cinnamond MJ. Hearing loss in diabetics. J Laryngol Otol. 1993;107:179-82. [PMID: 8509689] CrossrefMedlineGoogle Scholar3. Duck SW, Prazma J, Bennett PS, Pillsbury HC. Interaction between hypertension and diabetes mellitus in the pathogenesis of sensorineural hearing loss. Laryngoscope. 1997;107:1596-605. [PMID: 9396671] CrossrefMedlineGoogle Scholar4. Kakarlapudi V, Sawyer R, Staecker H. The effect of diabetes on sensorineural hearing loss. Otol Neurotol. 2003;24:382-6. [PMID: 12806288] CrossrefMedlineGoogle Scholar5. Ferrer JP, Biurrun O, Lorente J, Conget JI, de España R, Esmatjes E, et al. Auditory function in young patients with type 1 diabetes mellitus. Diabetes Res Clin Pract. 1991;11:17-22. [PMID: 2019230] CrossrefMedlineGoogle Scholar6. American Diabetes Association. Standards of medical care in diabetes—2008. Diabetes Care. 2008;31 Suppl 1 S12-54. [PMID: 18165335] CrossrefMedlineGoogle Scholar7. Bainbridge KE, Hoffman HJ, Cowie CC. Diabetes and hearing impairment in the United States: audiometric evidence from the National Health and Nutrition Examination Surveys, 1999 to 2004. Ann Intern Med. 2008;149:1-10. LinkGoogle Scholar8. Lisowska G, Namysłowski G, Morawski K, Strojek K. Cochlear dysfunction and diabetic microangiopathy. Scand Audiol Suppl. 2001;:199-203. [PMID: 11318468] CrossrefMedlineGoogle Scholar9. Fukushima H, Cureoglu S, Schachern PA, Kusunoki T, Oktay MF, Fukushima N, et al. Cochlear changes in patients with type 1 diabetes mellitus. Otolaryngol Head Neck Surg. 2005;133:100-6. [PMID: 16025061] CrossrefMedlineGoogle Scholar10. Fukushima H, Cureoglu S, Schachern PA, Paparella MM, Harada T, Oktay MF. Effects of type 2 diabetes mellitus on cochlear structure in humans. Arch Otolaryngol Head Neck Surg. 2006;132:934-8. [PMID: 16982969] CrossrefMedlineGoogle Scholar11. Smith TL, Raynor E, Prazma J, Buenting JE, Pillsbury HC. Insulin-dependent diabetic microangiopathy in the inner ear. Laryngoscope. 1995;105:236-40. [PMID: 7877409] CrossrefMedlineGoogle Scholar12. Nageris B, Hadar T, Feinmesser M, Elidan J. Cochlear histopathologic analysis in diabetic rats. Am J Otol. 1998;19:63-5. [PMID: 9455951] MedlineGoogle Scholar13. Di Nardo W, Ghirlanda G, Paludetti G, Cercone S, Saponara C, Del Ninno M, et al. Distortion-product otoacoustic emissions and selective sensorineural loss in IDDM. Diabetes Care. 1998;21:1317-21. [PMID: 9702440] CrossrefMedlineGoogle Scholar14. Ottaviani F, Dozio N, Neglia CB, Riccio S, Scavini M. Absence of otoacoustic emissions in insulin-dependent diabetic patients: is there evidence for diabetic cochleopathy? J Diabetes Complications. 2002;16:338-43. [PMID: 12200077] CrossrefMedlineGoogle Scholar15. Ferrary E, Sterkers O, Saumon G, Tran Ba Huy P, Amiel C. Facilitated transfer of glucose from blood into perilymph in the rat cochlea. Am J Physiol. 1987;253:F59-65. [PMID: 3111276] MedlineGoogle Scholar16. Kaźmierczak H, Doroszewska G. Metabolic disorders in vertigo, tinnitus, and hearing loss. Int Tinnitus J. 2001;7:54-8. [PMID: 14964957] MedlineGoogle Scholar Comments0 CommentsSign In to Submit A Comment Author, Article, and Disclosure InformationAuthors: Keiko Hirose, MDAffiliations: From Washington University, St. Louis, MO 63110.Disclosures: None disclosed.Corresponding Author: Keiko Hirose, MD, Washington University, Box 8115, 660 South Euclid Avenue, St. Louis, MO 63110; e-mail, [email protected]wustl.edu. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoDiabetes and Hearing Impairment in the United States: Audiometric Evidence from the National Health and Nutrition Examination Survey, 1999 to 2004 Kathleen E. Bainbridge , Howard J. Hoffman , and Catherine C. Cowie Metrics Cited byAlterations in hearing function of patients with glucose disordersBiomarkers of Systemic Inflammation and Risk of Incident Hearing LossAssociation between diabetes mellitus and hearing impairment in American and Korean populationsDecreased Expression of TRPV4 Channels in HEI-OC1 Cells Induced by High Glucose Is Associated with Hearing ImpairmentThe pathophysiological mechanisms of diabetic otopathyHearing loss and type 2 diabetes: is there a link?Glycosylated Hemoglobin Level Is Associated with Hearing Impairment in Older Japanese: The Kurabuchi StudyContributing factors to hearing of diabetic patients in an in-hospital education programSensorineural Hearing Loss-A Common Finding in Early-Onset Type 2 Diabetes Me LlitusChronological changes in compromised olivocochlear activity and the effect of insulin in diabetic Wistar ratsDiabetes-related changes in auditory brainstem responsesThe Link Between Diabetes and Hearing LossDiabetes-related changes in hearing 1 July 2008Volume 149, Issue 1Page: 54-55KeywordsCellsForecastingGlucoseHealth surveysHearingHyperglycemiaMicrocirculationNutritionResearch designRisk management ePublished: 1 July 2008 Issue Published: 1 July 2008 Copyright & PermissionsCopyright © 2008 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...